GQG Partners’s Bristol-Myers Squibb BMY Stock Holding History

GQG Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.81M	Buy	+46,361	New	+$2.7M	﹤0.01%	64
2025 Q3	–	Sell	-3,025,192	Closed	-$140M	–	96
2025 Q2	$140M	Sell	3,025,192 -8,998,262	-75%	-$442M	0.2%	53
2025 Q1	$733M	Buy	12,023,454 +11,970,598	+22,648%	+$698M	1.17%	29
2024 Q4	$2.99M	Buy	+52,856	New	+$2.95M	﹤0.01%	81
2023 Q2	–	Sell	-42,232	Closed	-$2.93M	–	72
2023 Q1	$2.93M	Sell	42,232 -471,183	-92%	-$33.2M	0.01%	67
2022 Q4	$36.9M	Buy	513,415 +51,365	+11%	+$3.87M	0.1%	50
2022 Q3	$32.9M	Sell	462,050 -1,015,421	-69%	-$73.7M	0.1%	47
2022 Q2	$114M	Buy	1,477,471 +871,872	+144%	+$66.4M	0.28%	42
2022 Q1	$44.2M	Buy	+605,599	New	+$40.7M	0.1%	45
2021 Q4	–	Sell	-17,071	Closed	-$1.01M	–	87
2021 Q3	$1.01M	Sell	17,071 -154	-0.9%	-$10.1K	﹤0.01%	59
2021 Q2	$1.15M	Buy	17,225 +6,856	+66%	+$447K	﹤0.01%	53
2021 Q1	$655K	Sell	10,369 -4,483,454	-100%	-$279M	﹤0.01%	55
2020 Q4	$279M	Buy	4,493,823 +3,783,133	+532%	+$233M	0.96%	36
2020 Q3	$42.8M	Sell	710,690 -3,044,997	-81%	-$183M	0.15%	52
2020 Q2	$221M	Buy	+3,755,687	New	+$225M	0.97%	34

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GQG Partners's BMY Position: Q1 2026 in Review

GQG Partners opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 46,361 shares worth $2.81M. The stake represents ﹤0.01% of the portfolio and ranks #64 among its holdings. This is a return to the name: GQG Partners previously reported a position in BMY as recently as Q2 2025.

GQG Partners first reported a position in BMY in Q2 2020 and has held it in 15 quarters since. The position peaked at $733M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

GQG Partners held 46,361 shares of Bristol-Myers Squibb worth $2.81M as of Q1 2026.
Bristol-Myers Squibb was a new GQG Partners position in Q1 2026.
Bristol-Myers Squibb made up ﹤0.01% of GQG Partners's portfolio in Q1 2026, its #64 holding.
GQG Partners first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 15 quarters since.
GQG Partners's Bristol-Myers Squibb position peaked at $733M in Q1 2025.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on GQG Partners's 13F filing for Q1 2026, filed 12 May 2026.